Cerebrolysin

EVER Pharma is a global specialist pharmaceutical company headquartered in Austria that focuses on the development and production of complex injectables for neurology, oncology, and intensive care. The company is best known for its flagship product, Cerebrolysin, a biotechnologically produced peptide preparation used to treat stroke, traumatic brain injury, and dementia. EVER Pharma operates high-tech production facilities in Austria and Germany, maintaining strict GMP standards for its diverse portfolio of specialty medicines and generics. With a presence in over 70 countries, the company provides essential therapies to hospitals and specialist clinics worldwide. Its business model integrates research, development, and international distribution to address unmet needs in critical care and neurodegenerative diseases.